Should Intra-cerebrospinal Fluid Prophylaxis Be Part of Initial Therapy for Patients With Non-Hodgkin Lymphoma: What We Know, and How We Can Find Out More
Ulrich Herrlinger, Michael Glantz, Uwe Schlegel, Christian Gisselbrecht, Franco Cavalli
Dive into the research topics of 'Should Intra-cerebrospinal Fluid Prophylaxis Be Part of Initial Therapy for Patients With Non-Hodgkin Lymphoma: What We Know, and How We Can Find Out More'. Together they form a unique fingerprint.